March 12, 2020 / 8:14 PM / 21 days ago

BRIEF-Mirum Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results And Provides Corporate Update

March 12 (Reuters) - Mirum Pharmaceuticals Inc:

* MIRUM PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* MIRUM PHARMACEUTICALS INC - NEW DRUG APPLICATION ROLLING SUBMISSION FOR ALAGILLE SYNDROME PLANNED TO BEGIN IN Q3 2020

* MIRUM PHARMACEUTICALS INC - ON TRACK FOR PFIC PHASE 3 TOP-LINE DATA AND LONG-TERM OUTCOMES NATURAL HISTORY COMPARISONS BY YEAR END

* MIRUM PHARMACEUTICALS INC - AS OF DECEMBER 31, 2019 MIRUM HAD CASH, CASH EQUIVALENTS AND INVESTMENTS OF $140.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below